Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania

Tropical Medicine and International Health

Volumn 19, Issue 9, 2014, Pages 1048-1056

  Mosha, Dominic ^a,b,c   Chilongola, Jaffu ^c   Ndeserua, Rabi ^d   Mwingira, Felista ^b   Genton, Blaise ^b,e  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b UNIVERSITY OF BASEL   (Switzerland)

^c KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

^d Muhimbili Orthopaedic Institute   (Tanzania)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Anaemia; IPTp SP; Low birthweight; Placental malaria

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PYRIMETHAMINE; SULFADOXINE;

ANEMIA; DISEASE TRANSMISSION; HEALTH RISK; MALARIA; PREGNANCY; WOMENS HEALTH;

ADULT; ANEMIA; ARTICLE; BIRTH WEIGHT; DRUG EFFICACY; FEMALE; HUMAN; INFECTION PREVENTION; INTERVIEW; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MICROSCOPY; MORBIDITY; OBSERVATIONAL STUDY; PLACENTA MALARIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; PRIMIGRAVIDA; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; STRUCTURED QUESTIONNAIRE; TANZANIA; YOUNG ADULT; ANÉMIE; BAJO PESO AL NACER; DISEASE TRANSMISSION; DRUG COMBINATION; FAIBLE POIDS DE NAISSANCE; IPTP-SP; MALARIA; MALARIA FALCIPARUM; MALARIA PLACENTARIA; NEWBORN; NUMBERS NEEDED TO TREAT; PALUDISME PLACENTAIRE; PARASITEMIA; PARASITOLOGY; PLACENTA; PLACENTA DISORDER; PREGNANCY COMPLICATION; RISK; TPI-SP; TREATMENT OUTCOME;

TANZANIA;

ANAEMIA; ANEMIA; ANÉMIE; BAJO PESO AL NACER; FAIBLE POIDS DE NAISSANCE; IPTP-SP; LOW BIRTHWEIGHT; MALARIA PLACENTARIA; PALUDISME PLACENTAIRE; PLACENTAL MALARIA; TPI-SP;

ADULT; ANEMIA; ANTIMALARIALS; BIRTH WEIGHT; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALARIA; MALARIA, FALCIPARUM; NUMBERS NEEDED TO TREAT; PARASITEMIA; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, PARASITIC; PREVALENCE; PROSPECTIVE STUDIES; PYRIMETHAMINE; RISK; SULFADOXINE; TANZANIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907289659     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12349     Document Type: Article

References (25)

1. Alifrangis M, Lusingu JP, Mmbando B et al. (2009) Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene. American Journal of Tropical Medicine and Hygiene 80, 523-527.
2. Brabin BJ, Romagosa C, Abdelgalil S et al. (2004) The sick placenta-the role of malaria. Placenta 25, 359-378.
3. D'acremont V, Kahama-Maro J, Swai N, Mtasiwa D, Genton B & Lengeler C (2011) Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-after and cluster randomized controlled study. Malaria Journal 10, 107.
4. Desai M, ter Kuile FO, Nosten F et al. (2007) Epidemiology and burden of malaria in pregnancy. The Lancet Infectious Diseases 7, 93-104.
5. Feng G, Simpson JA, Chaluluka E, Molyneux ME & Rogerson SJ (2010) Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS One 5, e12012.
6. Gamble C, Ekwaru PJ, Garner P & ter Kuile FO (2007) Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials. PLoS Medicine 4, e107.
7. Gesase S, Gosling RD, Hashim R et al. (2009) High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One 4, e4569.
8. Gutman J, Mwandama D, Wiegand RE, Ali D, Mathanga DP & Skarbinski J (2013) Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi. Journal of Infectious Diseases 208, 907-916.
9. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M & Duffy PE (2011) Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clinical Infectious Diseases 53, 224-230.
10. Hommerich L, von Oertzen C, Bedu-Addo G et al. (2007) Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Malaria Journal 6, 144.
11. Kabanywanyi AM, Macarthur JR, Stolk WA et al. (2008) Malaria in pregnant women in an area with sustained high coverage of insecticide-treated bed nets. Malaria Journal 7, 133.
12. Kayentao K, Garner P, van Eijk AM et al. (2013) Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA 309, 594-604.
13. ter Kuile FO, Terlouw DJ, Phillips-Howard PA et al. (2003) Impact of permethrin-treated bed nets on malaria and all-cause morbidity in young children in an area of intense perennial malaria transmission in western Kenya: cross-sectional survey. American Journal of Tropical Medicine and Hygiene 68, 100-107.
14. McClure EM, Goldenberg RL, Dent AE & Meshnick SR (2013) A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia. International Journal of Gynaecology and Obstetrics 121, 103-109.
15. Menendez C, Bardaji A, Sigauque B et al. (2008) A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 3, e1934.
16. MOH (2013) MTUHA Annual Report. Tanzania MOH.
17. Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK & Brabin B (2004) Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends in Parasitology 20, 425-432.
18. O'meara WP, Mangeni JN, Steketee R & Greenwood B (2010) Changes in the burden of malaria in sub-Saharan Africa. The Lancet Infectious Diseases 10, 545-555.
19. Plowe CV, Djimde A, Bouare M, Doumbo O & Wellems TE (1995) Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene 52, 565-568.
20. Savage EJ, Msyamboza K, Gies S, D'alessandro U & Brabin BJ (2007) Maternal anaemia as an indicator for monitoring malaria control in pregnancy in sub-Saharan Africa. BJOG 114, 1222-1231.
21. Schechtman E (2002) Odds ratio, relative risk, absolute risk reduction, and the number needed to treat-which of these should we use? Value in Health 5, 431-436.
22. TACAIDS, NBS, OCGS, ICF International March 2013. Tanzania HIV/AIDS and Malaria Indicator Survey: 2011-2012.
23. Wampfler R, Mwingira F, Javati S et al. (2013) Strategies for detection of Plasmodium species gametocytes. PLoS One 8, e76316.
24. WHO (2004). A Strategic Framework for Malaria Prevention and Control During Pregnancy in the Africa Region. WHO, Brazzaville.
25. WHO (2012) WHO Evidence Review Group: Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp) with Sulfadoxine-Pyrimethamine (SP). WHO, Geneva.